(Q46670739)

English

Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B.

scientific article published in February 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

0 references

1 reference

based on heuristic

inferred from title

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

Jimmie C. Holland

9

object named as

Jimmie Holland

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

Electra D Paskett

3

object named as

Electra D Paskett

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

author name string

A William Blackstock

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

James E Herndon

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

Michael C Perry

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

Stephen L Graziano

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

Joseph J Muscato

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

Michael P Kosty

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

Wallace L Akerley

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

Stewart Fleishman

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

Mark R Green

11

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

Journal of the National Cancer Institute

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

94

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

284-290

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Cancer statistics by race and ethnicity

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteria

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

The Analysis of Failure Times in the Presence of Competing Risks

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

The National Cancer Data Base report on lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Influence of extent of disease, histology, and demographic factors on lung cancer survival in the SEER population-based data

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Effects of health insurance and race on early detection of cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Factors that determine the treatment for local and regional prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F94.4.284

21 January 2018

Identifiers

10.1093/JNCI/94.4.284

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

release_uberk6xgt5gphpmnycwgmh4ydy

1 reference

https://api.fatcat.wiki/v0/release/uberk6xgt5gphpmnycwgmh4ydy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/11854390

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46670739&oldid=1840485270"